Supercharging Immunotherapies for Cancer and Immune Disorders

The Immunotherapy Stream at PEGS BOSTON highlights the most exciting technologies, modalities, and engineering strategies driving cellular and non-cellular immunotherapies for cancer and immune disorders. Part One examines recent breakthroughs in immunotherapy efficacy and safety, across a range of modalities; Part Two focuses on supercharging CAR T therapies and other cell immunotherapies against liquid and solid tumors; with Part Three focusing on the next generation of smarter, more targeted immunotherapies for reprogramming the immune system. All tracks feature brand new data, exciting, inspiring science, and unrivaled networking opportunities with both industry and academic leaders.

Conferences Include:

May 15-16

Improving Immunotherapy Efficacy and Safety

May 16-17

Cell-Based Immunotherapies

May 18-19

Next-Generation Immunotherapies

Keynote Presentations:

Immunomodulation by Genomic “Dark Matter” and Extracellular Vesicles in Cancer
Laszlo G. Radvanyi, PhD, President & Scientific Director, Ontario Institute for Cancer Research

Towards In Vivo Engineering of the Immune System
Adrian Bot, MD, PhD, CSO, Executive Vice President, R&D, Capstan Therapeutics

In vivo Engineering Considering Probability of Technical, Regulatory, and Commercial Success
Nicholas A. Boyle, PhD, CEO, Abintus Bio

2024 PROGRAMS

View By:

• Display of Biologics
• Engineering Antibodies
• Machine Learning for Protein Engineering

• Antibodies for Cancer Therapy
• Emerging Targets for Oncology
• Antibody Drug Conjugates

• TS: Intro to Bispecifics
• Advancing Bispecific Antibodies
• Engineering Bispecific Antibodies

• Advances in Immunotherapy
• Cell-Based Immunotherapy
• In vivo Cell and Gene Engineering

• Difficult-to-Express Proteins
• Optimizing Protein Expression
• Protein Production Workflows

• Digital Integration in Biotherapeutic Analytics
• Biophysical Methods
• Characterization for Novel Biotherapeutics

• TS: Intro to Immunogenicity
• Immunogenicity Assessment and Management
• TS: Intro to Bioassays

• Emerging Indications for Therapeutic Antibodies
• mRNA Therapeutics
• In vivo Cell and Gene Engineering